Literature DB >> 31322913

Comparison of 3T diffusion-weighted MRI and 18F-FDG PET/CT in musculoskeletal tumours: quantitative analysis of apparent diffusion coefficients and standardized uptake values.

So-Yeon Lee1, Won-Hee Jee1,2, Ie Ryung Yoo3, Joon-Yong Jung1, Soo-A Im1, Yang-Guk Chung4, Jin Hyoung Kang5.   

Abstract

OBJECTIVE: To determine whether the apparent diffusion coefficient (ADC) on 3T MR imaging including diffusion-weighted MR imaging (DWI) correlate with the standardized uptake value (SUV) on 18F-FDG PET/CT in musculoskeletal tumours.
METHODS: This retrospective cohort study included 57 patients (36 males, 21 females, mean age 54 years, range 12-90 years) with pathologically confirmed soft tissue (n = 32) and bone (n = 25) tumours who underwent 3T MR imaging including DWI and whole-body 18F-FDG PET/CT before treatment. 14 patients had follow-up MR imaging and 18F-FDG PET/CT after treatment. The minimum (ADCmin) and mean (ADCmean) ADCs of musculoskeletal tumour, ADC of normal skeletal muscle (ADCmus), SUVmax and SUVmean of musculoskeletal tumour were obtained. Correlation between ADCs and SUVs was assessed using Pearson correlation coefficients (r). ADCmin and SUVmax were compared between pretreatment and posttreatment by t-test.
RESULTS: There was inverse correlation between SUVmax and the ratio ADCmin/ADCmus (r = - 0.505 to - 0.495, p ≤ 0.001) and between SUVmean and the ratio ADCmean/ADCmus (r = - 0.501 to - 0.493, p = 0.001). After treatment ADC was significantly increased whereas SUV was significantly decreased (p = 0.001). There was significant correlation in percent change between the initial and follow-up values of ADCmin and SUVmax (r = 0.750 to 0.773, p ≤ 0.005). The ADCmin was increased by 163% and SUVmax was decreased by 61% in 11 patients with treatment response.
CONCLUSION: ADC at 3T MR DWI and SUV at 18F-FDG PET/CT have an inverse correlation in musculoskeletal tumours. ADVANCES IN KNOWLEDGE: Our study showed that ADC at 3T DWI and SUV at 18F-FDG PET/CT had an inverse correlation in musculoskeletal tumours.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31322913      PMCID: PMC6774587          DOI: 10.1259/bjr.20181051

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  34 in total

1.  Multiparametric voxel-based analyses of standardized uptake values and apparent diffusion coefficients of soft-tissue tumours with a positron emission tomography/magnetic resonance system: Preliminary results.

Authors:  Koji Sagiyama; Yuji Watanabe; Ryotaro Kamei; Sungtak Hong; Satoshi Kawanami; Yoshihiro Matsumoto; Hiroshi Honda
Journal:  Eur Radiol       Date:  2017-06-20       Impact factor: 5.315

2.  Correlations between intravoxel incoherent motion diffusion-weighted MR imaging parameters and 18F-FDG PET/CT metabolic parameters in patients with vertebral bone metastases: initial experience.

Authors:  Sunghoon Park; Joon-Kee Yoon; Nam-Su Chung; Sang Hyun Kim; Jinwoo Hwang; Hyun Young Lee; Kyu-Sung Kwack
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

3.  Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results.

Authors:  Yoshiko Hayashida; Toshitake Yakushiji; Kazuo Awai; Kazuhiro Katahira; Yoshiharu Nakayama; Osamu Shimomura; Mika Kitajima; Toshinori Hirai; Yasuyuki Yamashita; Hiroshi Mizuta
Journal:  Eur Radiol       Date:  2006-08-15       Impact factor: 5.315

4.  Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations.

Authors:  Carolin Reischauer; Johannes M Froehlich; Dow-Mu Koh; Nicole Graf; Christian Padevit; Hubert John; Christoph A Binkert; Peter Boesiger; Andreas Gutzeit
Journal:  Radiology       Date:  2010-09-09       Impact factor: 11.105

5.  FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.

Authors:  Mathieu Charest; Marc Hickeson; Robert Lisbona; Javier-A Novales-Diaz; Vilma Derbekyan; Robert E Turcotte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

6.  Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.

Authors:  Michele Gaeta; Caterina Benedetto; Fabio Minutoli; Tommaso D'Angelo; Ernesto Amato; Silvio Mazziotti; Santi Racchiusa; Enricomaria Mormina; Alfredo Blandino; Stefano Pergolizzi
Journal:  Acad Radiol       Date:  2014-08-01       Impact factor: 3.173

Review 7.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

8.  The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.

Authors:  Duk-Seop Shin; Oog-Jin Shon; Dong-Sung Han; Joon-Hyuk Choi; Kyung-Ah Chun; Ihn-Ho Cho
Journal:  Ann Nucl Med       Date:  2008-08-29       Impact factor: 2.668

9.  Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors.

Authors:  Matthias R Benz; Vladimir Evilevitch; Martin S Allen-Auerbach; Fritz C Eilber; Michael E Phelps; Johannes Czernin; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2008-06-13       Impact factor: 10.057

10.  Early response of breast cancer bone metastases to chemotherapy evaluated with MR imaging.

Authors:  I Ciray; H Lindman; K G Aström; J Bergh; K H Ahlström
Journal:  Acta Radiol       Date:  2001-03       Impact factor: 1.701

View more
  2 in total

1.  The role of 18F-FDG PET/CT in diagnosis and treatment evaluation for ocular adnexal mucosa-associated lymphoid tissue lymphoma.

Authors:  Weifang Wang; Xiaochen Ni; Tianci Tang; Jie Wang; Yi Li; Xinmao Song
Journal:  Br J Radiol       Date:  2021-12-17       Impact factor: 3.039

2.  Does the SUVmax of FDG-PET/CT Correlate with the ADC Values of DWI in Musculoskeletal Malignancies?

Authors:  Mesut Ozturk; Ahmet Veysel Polat; Fevziye Canbaz Tosun; Mustafa Bekir Selcuk
Journal:  J Belg Soc Radiol       Date:  2021-02-22       Impact factor: 1.894

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.